AXTI three-lens brief
Evidence-based stock research on AXTI. Three independent lenses — Foundation, Expansion, Climate — examine live data from SEC filings, the Federal Reserve, and market feeds. Every claim traces to its primary source.
Performance
Price down 6.11% in the last session — a material single-day move. · Negative free cash flow last quarterly (-$44.42M).
- Price down 6.11% in the last session — a material single-day move.
- 50-day MA above 200-day MA (golden-cross regime); price above both.
- Outperforming SPY by 71.1pp over 30 days.
- Analyst mean target $91.60 — 42% above current (5 analysts).
- Negative free cash flow last quarterly (-$44.42M).
AXTI closed at $64.70 (-6.11%) as of 2026-09-11. Market cap: $4.24B. Price is above the 50-day MA and above the 200-day MA. Positives: 50-day MA above 200-day MA (golden-cross regime); price above both.; outperforming SPY by 71.1pp over 30 days.. Concerns: price down 6.11% in the last session — a material single-day move.; negative free cash flow last quarterly (-$44.42M).. Last quarter: Revenue $47.59M, net income $11.13M, free cash flow -$44.42M.
Why three lenses on AXTI, not one.
A single reasoning model has blind spots it doesn’t know about. We examine AXTIacross Foundation (fundamentals), Expansion (growth runway and market expansion), and Climate (macro/sector). Disagreement between lenses is surfaced, not hidden — it’s how you know when HOLD is the honest call.
Read the full methodologyDrop it in your newsletter or blog.
Free to embed. Updates every 6 hours. Links back to the full brief.
<iframe src="https://clearpathinvest.app/embed/AXTI" width="100%" height="420" frameborder="0" loading="lazy" title="ClearPath AXTI brief"></iframe>